IP Library Granted Patent US 12,569,639
Granted Patent B2
US 12,569,639 · App. 17/870,820 · Granted Mar 10, 2026

Efficient enriched oxygen airflow systems and methods

Inventor: John Warren (Melville, CA)
A61M16/101A61M16/024A61M16/0672A61M2016/0036A61M2016/1025A61M2202/0057A61M2202/0208A61M2202/0266A61M2205/3334
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,569,639
App. No.
17/870,820
Granted
Mar 10, 2026
Kind
B2
Abstract

The present invention provides new devices, systems, and methods for delivering enriched oxygen to recipients (e.g., chronically ill patients, such as COPD patients). One aspect is a more efficient portable oxygen concentrator that is configured to deliver an enriched oxygen airflow having a significantly lower overall oxygen concentration and greater overall volume administered as compared to currently marketed or known portable oxygen concentrators. Administering the lower oxygen concentration at higher volumes allows for the present portable oxygen concentrators to deliver an equivalent number of moles of oxygen as administered by traditional portable concentrators while increasing the efficiency of the system and the ability of the system to maintain the therapeutic level of oxygen concentration for a longer period.

Claims (28)

1 . A system for assisting breathing in a patient having low blood oxygen saturation, comprising:

(1) a portable oxygen concentrator configured to deliver an enriched oxygen airflow, wherein the portable oxygen concentrator comprises:

(a) a pressure gradient generating system;

(b) at least one nitrogen adsorption media that generates the enriched oxygen airflow when exposed to air and acted on by a sufficient pressure gradient and that is selectively isolated from an ambient environment by at least one air enrichment area separator;

(c) an enriched oxygen airflow outlet that is fluidly connected to a flow line and a patient oxygen delivery interface;

(d) a programmable controller comprising stored non-transitory computer readable instructions and a processor for executing the stored instructions and wherein the controller is configured to determine:

(I) a volume of the airflow delivered to the patient,

(II) an oxygen concentration of the airflow, and

(III) whether to deliver enriched oxygen airflow to the patient via continuous delivery or pulse delivery;

(e) one or more sensors configured to detect changes in patient oxygen intake, and

(f) an alarm that is configured to relay an alert when the oxygen airflow administered changes from a moderately enriched oxygen airflow to a highly enriched oxygen airflow or an intensively enriched oxygen airflow, wherein the portable oxygen concentrator is configured to:

(I) deliver the enriched oxygen airflow to the patient for a period of at least 1 month, the delivery of the enriched oxygen airflow comprising a therapeutically effective amount of moderately enriched oxygen airflow comprising an oxygen concentration of between 30-49%,

(II) monitor the breathing of the patient through the one or more sensors configured to detect changes in patient oxygen intake, and

(III) automatically switch between at least one pulse delivery mode and a continuous delivery mode wherein in the continuous delivery mode the portable oxygen concentrator is configured to automatically:

(A) generate an intensively enriched oxygen airflow comprising an oxygen concentration of at least about 60% and

(B) continuously deliver between about 640 mL and about 1200 mL of the intensively enriched oxygen airflow to the patient per average inspiration based on a timing of detection of breathing of the patient through the one or more sensors when the controller determines that one or more aspects of the patient's breathing meets or exceeds one or more pre-programmed thresholds; and wherein the portable oxygen concentrator is configured to consume an average of 30-60 Watts of energy during operation.

2 . The system of claim 1 , wherein the system is configured to treat chronic obstructive pulmonary disease.

3 . The system of claim 1 , wherein the oxygen concentration of the intensively enriched oxygen airflow is at least about 75%.

4 . The system of claim 1 , wherein the continuous delivery mode is configured to deliver the highly enriched oxygen airflow to the patient, wherein the highly enriched airflow comprises an oxygen concentration of at least about 90%.

5 . The system of claim 1 , wherein the portable oxygen concentrator is configured to detect patient inspirations and automatically deliver at least about 75% of a pulse of moderately enriched oxygen within about 500 milliseconds of the detection of an inspiration.

6 . The system of claim 5 , wherein the portable oxygen concentrator is configured to detect patient inspirations and automatically deliver at least about 75% of the pulse of moderately enriched oxygen within about 300 milliseconds of the detection of the inspiration.

7 . The system of claim 1 , wherein generating the moderately enriched oxygen airflow comprises applying the pressure gradient, wherein the pressure gradient comprises applying a maximum pressure of between 15-25 PSI to the nitrogen adsorption media.

8 . The system of claim 1 , wherein the one or more sensors are configured to detect patient inhalation and exhalation and the at least one pulse delivery mode is configured to deliver an initial pulse of oxygen upon detection of inhalation and thereafter delivering a declining continuous flow of the enriched oxygen airflow until the one or more sensors detects that the patient has exhaled.

9 . The system of claim 1 , wherein the system further comprises a manual shut off for the alarm feature that is configured to be selectively activated by the patient.

10 . The system of claim 1 , wherein the system is configured to administer oxygen to the patient in the at least one pulse delivery mode in an amount of between about 80 ml and about 600 ml of moderately enriched airflow per inspiration.

11 . The system of claim 10 , wherein the oxygen is configured to be administered to the patient in the at least one pulse delivery mode in an amount of at least 280 ml per inspiration.

12 . The system of claim 11 , wherein the moderately enriched airflow has an oxygen concentration of between 30% and 39%.

13 . The system of claim 1 , wherein the alarm is configured to relay an alert when the volume of airflow delivered by the system falls below a minimum airflow.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 7, 2025
From: WEARAIR VENTURES, INC.
To: WEARAIR VENTURES 2024, INC., NUMBER BC1506953
Reel/Frame 072500/0623 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 30, 2022
From: WARREN, JOHN
To: WEARAIR VENTURES, INC.
Reel/Frame 061929/0699 →
Continuity (4)
Continuation In Part 17850804 · Jun 27, 2022
Continuation 17141085 · Jan 4, 2021
Provisional Application 62995224 · Jan 21, 2020
Related Publication 20230023722A1 · Jan 26, 2023
References Cited (61)
US 3533221A · Tamura · 1970 [cited by applicant]
US 4971609A · Pawlos · 1990 [cited by applicant]
US 6520176B1 · Dubois · 2003 [cited by applicant]
US 6651658B1 · Hill · 2003 [cited by applicant]
US 6691702B2 · Appel · 2004 [cited by applicant]
US 7763103B2 · Dolensky · 2010 [cited by applicant]
US 8894751B2 · Galbraith · 2014 [cited by applicant]
US 9717876B2 · Wilkinson · 2017 [cited by applicant]
US 9974918B2 · Armstrong · 2018 [cited by applicant]
US 9974919B2 · Richard · 2018 [cited by applicant]
US 10583265B2 · Whitcher · 2020 [cited by applicant]
US 10799663B1 · Oddo · 2020 [cited by applicant]
US 11951260B2 · Warren · 2024 [cited by examiner]
US 20030167924A1 · McCombs · 2003 [cited by examiner]
US 20060185668A1 · Jagger · 2006 [cited by examiner]
US 20060230931A1 · Bliss · 2006 [cited by applicant]
US 20070227360A1 · Atlas · 2007 [cited by examiner]
US 20090320845A1 · Fishman · 2009 [cited by examiner]
US 20100116270A1 · Edwards · 2010 [cited by applicant]
US 20110197890A1 · Jagger · 2011 [cited by applicant]
US 20110232483A1 · Haberland · 2011 [cited by examiner]
US 20110247620A1 · Armstrong · 2011 [cited by examiner]
US 20120000462A1 · Edwards · 2012 [cited by applicant]
US 20120266883A1 · Taylor · 2012 [cited by applicant]
US 20140345609A1 · Whitcher · 2014 [cited by applicant]
US 20150059764A1 · Metelits · 2015 [cited by applicant]
US 20150083121A1 · Fisher · 2015 [cited by applicant]
US 20200179638A1 · Oddo · 2020 [cited by examiner]
US 20200306486A1 · Oddo · 2020 [cited by applicant]
US 20200360644A1 · Westfall · 2020 [cited by applicant]
US 20210093824A1 · Colefax · 2021 [cited by applicant]
US 20210113801A1 · Wang · 2021 [cited by examiner]
US 20210154427A1 · Poon · 2021 [cited by examiner]
US 20210196916A1 · Rauker · 2021 [cited by applicant]
US 20230023722A1 · Warren · 2023 [cited by applicant]
CA 2810669 · 2012 [cited by applicant]
CN 202322372 · 2012 [cited by applicant]
EP 1401557 · 2004 [cited by applicant]
EP 1637209 · 2006 [cited by applicant]
EP 3193996 · 2017 [cited by applicant]
GB 955894 · 1964 [cited by applicant]
JP 2007536759 · 2008 [cited by applicant]
JP 2008517638 · 2008 [cited by applicant]
JP 2010227517 · 2010 [cited by applicant]
WO WO2011127314 · 2011 [cited by applicant]
WO WO2015015852 · 2015 [cited by applicant]
WO WO2019202390 · 2019 [cited by applicant]
WO WO2020037375 · 2020 [cited by applicant]
Final Office Action on Aug. 2, 2023 for U.S. Appl. No. 17/850,804. [cited by applicant]
Non-Final Office Action on Apr. 30, 2021 for U.S. Appl. No. 17/141,085. [cited by applicant]
Final Office Action on Aug. 17, 2021 for U.S. Appl. No. 17/141,085. [cited by applicant]
Non-Final Office Action on Dec. 27, 2021 for U.S. Appl. No. 17/141,085. [cited by applicant]
Non-Final Office Action on Mar. 1, 2023 for U.S. Appl. No. 17/850,804. [cited by applicant]
Sakaue, et al., “Oxygen Inhalation Using an Oxygen Concentrator in Low-Pressure Environment Outside of a Hospital”, The American Journal of Emergency Medicine, vol. 26, Issue 9, p. 981-984, Nov. 1, 2008. [cited by applicant]
Oxygen Concentrator/SET, S0002047 Product Information. [cited by applicant]
Miller, GW and Fenner, JE. “A “Smart” Molecular Sieve Oxygen Concentrator with Continuous Cycle Time Adjustment”, Air Force Materiel Command Brooks Air Force Base, Texas, Apr. 1996; Final Technical Paper for Period Oct.… [cited by applicant]
Katz, et al., “An in silico analysis of oxygen uptake of a mild COPD patient during rest and exercise using a portable oxygen concentrator”, International Journal COPD, 2016:2427-2434. [cited by applicant]
Hardavella, et al., “Oxygen Devices and Delivery System”, Breathe, Sep. 2019, vol. 15, No. 3. [cited by applicant]
Williams, Paul Robert, “Characterization and Feasibility of a Portable Oxygen Concentrator for use with a Mass Casualty Ventilator”, thesis for Boise State University, Dec. 2013. [cited by applicant]
Driscoll, et al., “Emergency Oxygen Therapy for the COPD Patient”, Emerg Med J 2001; 18:333-339. [cited by applicant]
Brill, et al, “Oxygen Therapy in Acute Exacerbations of Chronic Obstructive Pulmonary Disease” International Journal of COPD, 2014:9, 1241-1252. [cited by applicant]